Advanced Search

Home > Journals > Panminerva Medica > Past Issues > Articles online first > Panminerva Medica 2016 Jun 30



A Journal on Internal Medicine

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Frequency: Quarterly

ISSN 0031-0808

Online ISSN 1827-1898


Panminerva Medica 2016 Jun 30

Targeting transradial approach: an updated systematic review and meta-analysis of randomized controlled trials

Francesca DEL FURIA 1, Gennaro GIUSTINO 1, 2, Alaide CHIEFFO 1

1 San Raffaele Scientific Institute, Interventional Cardiology Unit, Milan, Italy; 2 Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai, New York, US

BACKGROUND: Transradial access (TRA) emerged in the last two decades as a valid alternative to the standard transfemoral access (TFA) for cardiac catheterization and percutaneous coronary intervention (PCI). Due to contrasting results, the penetration and uptake of TRA in real-world clinical practice has been slow and still limited to high experienced center.
METHODS: We performed an updated systematic review and study-level meta-analysis of randomized controlled trials (RCTs) that investigated the efficacy and safety of TRA versus TFA for PCI in patients with ACS. MEDLINE, Scopus, the Cochrane Library, and were searched for abstracts, manuscripts, and conference reports published until April 31, 2016. The three pre-specified primary endpoints of interest were: all-cause mortality, major bleeding and major adverse cardiac events (MACE), at 30 days of follow-up. Primary analytic approach was according the intention-to-treat principle using inverse variance weighted random effect models.
RESULTS: Study level data from 12 RCTs were extracted and analyzed. TRA compared with TFA in ACS patients undergoing invasive management was associated with a significant reduction in the risk of mortality (RR 0.72; 95% CI, 0.59–0.88; p=0.002), major bleeding (RR 0.48; 95% CI, 0.37– 0.61; p<0.00001) and MACE (RR 0.81; 95% CI, 0.69–0.96; p=0.01), with similar procedural rate of success. In addition, TRA was associated with reduced in-hospital length of stay. There were no differences in the risk of stroke, myocardial infarction and target vessel or target lesion revascularization.
CONCLUSIONS: The results of the present study confirm TRA as the preferred routine upfront strategy for ACS patients undergoing PCI.

language: English


top of page